Baseline Testing Sample Clauses

Baseline Testing. Those employees who are or may be exposed to hazardous substances or health hazards, including dangerous drugs or dangerous chemicals used for the manufacture of drugs, at or above permissible exposure limits (as defined by OSHA regulations) in the course and scope of their employment shall be tested by the Agency for exposure to the hazardous substance as follows: A. Baseline drug test prior to assignment to an area where employees will be or may be exposed to hazardous substances or health hazards. B. At least once every twelve (12) months thereafter unless the employee’s attending physician believes a longer interval is appropriate, but not to exceed biannual exams. C. At termination or reassignment to an area where exposure will not occur if the employee has not had an examination within the preceding six (6) months. D. As soon as possible after notification that signs or symptoms indicating possible overexposure have developed or, an injury has occurred, or exposure above the permissible exposure limits or published exposure levels has occurred in an emergency situation, and E. Where the employee’s attending physician determines that examinations on a basis more frequently than that outlined above are medically necessary. The test will be done at Agency’s expense and on Agency time.
View SourceView Similar (9)
Baseline Testing. The Employer has the discretion to conduct baseline testing, meaning the testing of all workers at a specific site. Such testing may be conducted on a random basis and may involve testing of workers on specific sites only.
View SourceView Similar (4)
Baseline Testing. If a Water Source was tested only prior to January 1, 2019, and its test results do not show a Measurable Concentration of PFAS, that Water Source must be retested to meet Baseline Testing requirements. If a Water Source was tested on January 1, 2019, or later, and its test results do not show a Measurable Concentration of PFAS, no further testing of that Water Source is required. Test results may be submitted from untreated (raw) or treated (finished) water samples. However, all samples must be drawn from a Water Source that has been used to provide Drinking Water. For any questions about this Supplemental Claims Form, you may contact at . Claims Forms submitted by mail should be sent to the Claims Administrator at the following address: AFFF Public Water System Claims PO Box 4466 Baton Rouge, LA 70821
View SourceView Similar (2)
Baseline Testing. The Employer has the discretion to conduct baseline testing, meaning the testing of all workers at a specific site. Such testing may be conducted on a random basis and may involve testing of workers on specific sites only. Any worker who is involved in a work-related accident (as defined below) will be tested for the use of illegal drugs and/or alcohol as soon as possible after the accident. Examples of an accident that will require a worker to take a drug and/or alcohol test include, but are not limited to, accidents that are caused by a worker and result in one of the following:
View Source
Baseline Testing. If a Water Source was tested only prior to January 1, 2019, and its test results do not show a Measurable Concentration (any level) of PFAS, that Water Source must be retested to meet Baseline Testing requirements. If a Water Source was tested on January 1, 2019, or later, and its test results do not show a Measurable Concentration of PFAS, no further testing of that Water Source is required. Test results may be submitted from untreated (raw) or treated (finished) water samples. However, all samples must be drawn from a Water Source that has been used to provide Drinking Water. A PWS that does not timely return a completed Claims Form forfeits any right to participate in this settlement. For any questions about this Claims Form, you may contact at . Claims Forms submitted by mail should be sent to the Claims Administrator at the following address: AFFF Public Water System Claims PO Box 4466 Baton Rouge, LA 70821
View Source
Baseline Testing. The Parties acknowledge that, in August 2020 and prior to Contractor’s occupation and use of the Facility, District conducted Hazardous Substances testing on and about the Facility and shared the test results with Contractor. The Parties agree that this testing shall establish the baseline for Hazardous Substances at the Facility. At any time, District may require additional testing to detect the presence of Hazardous Substances by the use of any tests that are then customarily used for those purposes.
View Source
Baseline Testing. Those employees who are or may be exposed to hazardous substances or health hazards, including dangerous drugs or dangerous chemicals used for the manufacture of drugs, at or above permissible exposure limits (as defined by OSHA regulations) in the course and scope of their employment shall be tested by the City for exposure to the hazardous substance as follows: 1. Baseline drug test prior to assignment to an area where employees will be or may be exposed to hazardous substances or health hazards. 2. At least once every twelve (12) months thereafter unless the employee’s attending physician believes a longer interval is appropriate, but not to exceed biannual exams. 3. At termination or reassignment to an area where exposure will not occur if the employee has not had an examination within the preceding six (6) months. 4. As soon as possible after notification that signs or symptoms indicating possible overexposure have developed or, an injury has occurred or exposure above the permissible exposure limits or published exposure levels has occurred in an emergency situation. 5. Where the employee’s attending physician determines that examinations on a basis more frequently than that outlined above are medically necessary. The test will be done at City’s expense and on City time.
View Source
Baseline Testing a. Each Qualifying Class Member must test each of its Water Sources for PFAS, request from the laboratory that performs the analyses all analytical results, including the actual numeric values, and submit detailed PFAS test results to the Claims Administrator on a Claims Form by dates specified below. This process is referred to as Baseline Testing. b. Any Qualifying Class Member that has an Impacted Water Source based on a test conducted on or before the Settlement Date does not need to test that Water Source again for purposes of Baseline Testing. c. If a Water Source was tested only prior to January 1, 2019, and its test results do not show a Measurable Concentration of PFAS, that Water Source must be retested to meet Baseline Testing requirements. If a Water Source was tested on January 1, 2019, or later, and its test results do not show a Measurable Concentration of PFAS, no further testing of that Water Source is required. d. Baseline Testing requires the following: i. PFAS tests must be conducted at a minimum for the 29 PFAS analytes for which UCMR-5 requires testing, and ii. the PFAS test results must report any Measurable Concentration of PFAS, regardless of whether the level of PFAS detected in the water is above or below UCMR-5’s relevant minimum reporting level. e. Failure to test and submit Qualifying Test Results for Water Sources will disqualify Water Sources from consideration for present and future payments.
View Source
Baseline Testing. If a Water Source was tested only prior to January 1, 2019, and its test results do not show a Measurable Concentration (any level) of PFAS, that Water Source must be retested to meet Baseline Testing requirements. If a Water Source was tested on January 1, 2019, or later, and its test results do not show a Measurable Concentration of PFAS, no further testing of that Water Source is required. Test results may be submitted from untreated (raw) or treated (finished) water samples. However, all samples must be drawn from a Water Source that has been used to provide Drinking Water. A PWS that does not timely return a completed Claims Form forfeits any right to participate in this settlement. For any questions about this Claims Form, you may contact a Claim Representative at ▇-▇▇▇-▇▇▇-▇▇▇▇ or ▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇. Claims Forms submitted by mail should be sent to the Claims Administrator at the following address: AFFF Public Water System Claims PO Box 4466 Baton Rouge, LA 70821
View Source

Related to Baseline Testing

  • Performance Testing (a) All performance tests of the Project, including any Initial Performance Test required in Section 2 of Appendix VIII, will be performed in accordance with the test procedures set forth in Appendix VIII (“Performance Test”), including additional procedures and protocols related to Performance Testing as mutually agreed between Buyer and Seller (“Test Procedures”). Seller shall bear all costs and receive all revenues, if applicable, associated with all Performance Tests. (b) After the Initial Delivery Date and during the Delivery Term, Buyer will have the right to conduct a Performance Test (“Buyer Performance Test”) no more than once a calendar year to demonstrate whether the Project is capable of delivering the Distribution Services at the Contract Capacity. Within 30 calendar days following a Buyer Performance Test, Seller will have the right to retest the Project with a Performance Test (“Seller Retest”). For the avoidance of doubt, the results of any Seller Retest will supersede the results of the preceding Buyer Performance Test. (i) If a Buyer Performance Test or, if a corresponding Seller Retest has occurred, a Seller Retest demonstrates the Project is capable of delivering Distribution Services at or above ninety-nine percent (99%) of the Initial Contract Capacity, the Contract Capacity will remain the Initial Contract Capacity; (ii) If a Buyer Performance Test or, if a corresponding Seller Retest has occurred, a Seller Retest demonstrates the Project is capable of delivering Distribution Services at more than or equal to eighty-five (85%) of the Initial Contract Capacity, but less than ninety-nine percent (99%) of the Initial Contract Capacity (“Testing Band”), the Contract Capacity will be automatically adjusted (upwards or downwards) to the capacity commensurate with the amount of Distribution Services the Project delivered during the Performance Test within the Testing Band. (iii) If a Buyer Performance Test or, if a corresponding Seller Retest has occurred, a Seller Retest demonstrates the Project is not capable of delivering Distribution Services of at least eighty-five percent (85%) of the Initial Contract Capacity, an Event of Default shall occur in accordance with Section 7.1(a)(viii).

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.

  • Performance Tests Contractor shall perform Performance Tests in accordance with Section 11.2 of the Agreement and Attachment S.

  • Stability Testing Patheon will conduct stability testing on the Products in accordance with the protocols set out in the Specifications for the separate fees and during the time periods set out in Schedule C. Patheon will not make any changes to these testing protocols without prior written approval from Client. If a confirmed stability test failure occurs, Patheon will notify Client within [***], after which Patheon and Client will jointly determine the proceedings and methods to be undertaken to investigate the cause of the failure, including which party will bear the cost of the investigation. Patheon will not be liable for these costs unless it has failed to perform the Manufacturing Services in accordance with the Specifications and cGMPs. Patheon will give Client all stability test data and results at Client’s request.